Jul. 12, 2023 6:17 PM ETEli Lilly and Company (LLY)By: Jonathan Block, SA News Editor1 Comment
Paperkites
- Eli Lilly (NYSE:LLY) said that its Q2 2023 results will include acquired IPR&D charges of approximately $97M, a charge of $0.09 on earnings per share.
- The drugmaker said it does not project IPR&D charges “due to the uncertainty of the future occurrence, magnitude, and timing of these transactions in any given period.”
- Lilly is set to report Q2 earnings on Aug. 8. The GAAP EPS estimate is $1.71 while the non-GAAP estimate is $2.02.
Comments (1)
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.
a
astroboy
Yesterday, 9:24 PM
Premium
Comments (8)
LLY mooned too much. Will probably come back down a bit.